INVO Fertility, Inc. (IVF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INVO Fertility, Inc. (IVF) has a cash flow conversion efficiency ratio of -0.304x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.78 Million) by net assets ($5.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of INVO Fertility, Inc. for the company's overall valuation and market capitalisation.
INVO Fertility, Inc. - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how INVO Fertility, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
INVO Fertility, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INVO Fertility, Inc. ranked by their cash flow conversion efficiency. Explore IVF cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Akanda Corp
NASDAQ:AKAN
|
0.530x |
|
INCUVO S.A. ZY -50
F:68X
|
0.135x |
|
Mantex AB
ST:MANTEX
|
-1.685x |
|
BELGRAVIA HARTFORD CAP.
F:ECA
|
1.398x |
|
Bohra Industries Limited
NSE:BOHRAIND
|
0.009x |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
-0.416x |
|
WILDCAT PRETR.LS -000028
F:8Y6
|
N/A |
|
Heritage Distilling Holding Company, Inc.
NASDAQ:IPST
|
-0.076x |
Annual Cash Flow Conversion Efficiency for INVO Fertility, Inc. (2006–2024)
The table below shows the annual cash flow conversion efficiency of INVO Fertility, Inc. from 2006 to 2024. View IVF stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $12.75 Million | $-2.97 Million | -0.233x | +95.62% |
| 2023-12-31 | $892.60K | $-4.76 Million | -5.327x | -178.87% |
| 2022-12-31 | $-977.61K | $-6.60 Million | 6.755x | +918.92% |
| 2021-12-31 | $7.31 Million | $-6.03 Million | -0.825x | +0.80% |
| 2020-12-31 | $5.74 Million | $-4.78 Million | -0.831x | -125.29% |
| 2019-12-31 | $-3.71 Million | $1.37 Million | -0.369x | -253.97% |
| 2018-12-31 | $-2.72 Million | $-652.97K | 0.240x | +560.10% |
| 2017-12-31 | $-4.99 Million | $-181.27K | 0.036x | -48.23% |
| 2016-12-31 | $-4.62 Million | $-323.90K | 0.070x | +73.81% |
| 2015-12-31 | $-3.76 Million | $-151.62K | 0.040x | +806.74% |
| 2014-12-31 | $-4.36 Million | $-19.40K | 0.004x | -71.66% |
| 2013-12-31 | $-3.81 Million | $-59.92K | 0.016x | +22.60% |
| 2012-12-31 | $-3.37 Million | $-43.21K | 0.013x | -68.18% |
| 2011-12-31 | $-2.93 Million | $-117.78K | 0.040x | -68.38% |
| 2010-12-31 | $-2.48 Million | $-315.99K | 0.127x | -57.65% |
| 2009-12-31 | $-3.08 Million | $-926.66K | 0.301x | -93.61% |
| 2008-12-31 | $-226.57K | $-1.07 Million | 4.708x | +309.46% |
| 2007-12-31 | $-100.93K | $-116.04K | 1.150x | +4369.14% |
| 2006-12-31 | $37.54K | $-1.01K | -0.027x | -- |
About INVO Fertility, Inc.
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body… Read more